DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Public ClinicalTrials.gov record NCT03237325. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Study identification
- NCT ID
- NCT03237325
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Soligenix
- Industry
- Enrollment
- 266 participants
Conditions and interventions
Interventions
- SGX942 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2017
- Primary completion
- Jun 23, 2020
- Completion
- Jun 23, 2021
- Last update posted
- Nov 7, 2022
2017 – 2021
United States locations
- U.S. sites
- 32
- U.S. states
- 22
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| Loma Linda University Health | Loma Linda | California | 92354 | — |
| Pomona Valley Hospital Medical Center | Pomona | California | 91767 | — |
| Cancer Specialists of North Florida | Jacksonville | Florida | 32256 | — |
| Lakes Research | Miami Lakes | Florida | 33014 | — |
| University Cancer & Blood | Athens | Georgia | 30607 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Memorial Health | Savannah | Georgia | 31404 | — |
| University of Illinois Cancer Center | Chicago | Illinois | 60612 | — |
| Carle Cancer Center | Urbana | Illinois | 61801 | — |
| Des Moines Oncology Research Association | Des Moines | Iowa | 50309 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Ashland Bellefonte Cancer Center | Ashland | Kentucky | 41101 | — |
| Willis Knighton Cancer Center | Shreveport | Louisiana | 71103 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Minnesota Oncology | Saint Louis Park | Minnesota | 55416 | — |
| University of Missouri-Ellis Fischel Cancer Center | Columbia | Missouri | 65203 | — |
| Great Falls Clinic | Great Falls | Montana | 59405 | — |
| CHI Health St. Francis | Grand Island | Nebraska | 68803 | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89052 | — |
| Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | — |
| Hackensack Meridian Health | Neptune City | New Jersey | 07753 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Summa Health Cancer Research | Akron | Ohio | 44304 | — |
| The Christ Hospital | Cincinnati | Ohio | 45219 | — |
| Mercy Clinic Oncology and Hematology | Oklahoma City | Oklahoma | 73120 | — |
| Oklahoma Cancer Specialists | Tulsa | Oklahoma | 74146 | — |
| Charleston Cancer Center | Charleston | South Carolina | 29406 | — |
| Spartanburg Regional-Gibbs Cancer Center | Spartanburg | South Carolina | 29303 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03237325, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03237325 live on ClinicalTrials.gov.